- Idiopathic Membranous Nephropathy (MN)
- Focal Segmental Glomerulosclerosis (FSGS)
- Minimal Change Disease (MCD)
- Membranoproliferative Glomerulonephritis (MPGN)
- Lupus Nephritis (LN)
- IgA Nephropathy (IgA)
TheStreet's Adam Feuerstein lays down his predictions for the biotech industry for 2015.
I can't remember the last time a company got more than a slap on the wrist.